Stage A HF is defined as ...

Stage A HF is defined as ...

• A. Structural heart disease with HF symptoms
• B. At risk but no symptoms (hypertension, coronary artery disease, diabetes, family history)
• C. No symptoms but decreased EF & signs of structural disease
• D. Refractory HF symptoms at rest despite therapy

Answer: (B)

Stage A heart failure is about being at high risk for developing heart failure without having any structural heart disease or symptoms yet. It includes people who have risk factors such as high blood pressure, coronary artery disease, diabetes, or a family history of heart disease, but there are no signs or symptoms of HF and no detectable structural changes. The goal at this stage is prevention: aggressively manage risk factors, optimize blood pressure and metabolic health, and monitor for any signs that heart structure or function is changing. Other descriptions reflect different stages: having structural heart disease with symptoms points to a later stage where HF symptoms are present; having no symptoms but visible structural changes like reduced ejection fraction fits a stage where structural disease exists without symptoms; and persistent symptoms despite therapy at rest denotes a more advanced stage requiring specialized intervention.

Stage A heart failure is about being at high risk for developing heart failure without having any structural heart disease or symptoms yet. It includes people who have risk factors such as high blood pressure, coronary artery disease, diabetes, or a family history of heart disease, but there are no signs or symptoms of HF and no detectable structural changes. The goal at this stage is prevention: aggressively manage risk factors, optimize blood pressure and metabolic health, and monitor for any signs that heart structure or function is changing.

Other descriptions reflect different stages: having structural heart disease with symptoms points to a later stage where HF symptoms are present; having no symptoms but visible structural changes like reduced ejection fraction fits a stage where structural disease exists without symptoms; and persistent symptoms despite therapy at rest denotes a more advanced stage requiring specialized intervention.